Shivalik Rasayan Limited — Results, 25-03-2025: Reply to Clarification- Financial results

Shivalik Rasayan Limited has announced a board meeting to approve the un-audited financial results for the quarter and nine months ended December 31, 2024. The key figures reported include consolidated net sales of ₹8,530.61 crore and a net profit of ₹693.79 crore for the quarter. Notably, the Agrochemicals segment contributed significantly to revenue, while the Active Pharmaceutical Ingredients (API) segment experienced a loss. The revised financial results were shared following feedback from the National Stock Exchange regarding earlier submissions.

This update indicates robust performance, particularly in Agrochemicals, enhancing a positive outlook for shareholders. However, the API segment's losses may pose ongoing risks. Overall, the company's continued growth in key sectors is promising for investor confidence.